In this article the authors assessed the clinical and laboratory features of 11 patients in Germany and Austria in whom thrombosis or thrombocytopenia had developed after vaccination with ChAdOx1 nCov-19.

EAN members receive free access to the ebrain learning platform. The website has a new look and layout for 2021 plus a new podcast series – “Ten Minute Urgent Neurology” by Adrian Wills, ebrain Clinical Lead.

Patient involvement in the education of healthcare professionals has been identified already several years ago as a priority[1][1] to ensure the future health workforce have the skills, knowledge and attitudes to practice truly person-centred care – including shared decision-making, listening, supportive and effective communication, empathy and partnership.

The BioMed Alliance signed a Memorandum of Understanding (MoU) with EIT Health to facilitate cooperation related to education and the promotion of innovation.

EAN has joined with Euro-CNS to promote and maintain the harmonisation of neuropathology training and clinical practice in Europe and advance optimal care and management for patients in Europe.

General Secretary, Elena Moro, welcomes the future generations of neurologists and neuroscientists to our Congress & community

Jes Olesen, winner of the 2021 Brain Prize I am very pleased to be asked for an interview on the occasion on my receipt of The Brain Prize. EAN is very close to my heart and I regard it as… Continue Reading

For May 2021, we have selected: Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 202;372:n311. doi: 10.1136/bmj.n311.

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Brazil)

COVID-19 around the World: Clinician interviews on experience and impact of the virus (India)

Many pregnant people in the United States have received mRNA COVID-19 vaccines, but data are limited on their safety in pregnancy. The authors of this study used data from the “v-safe after vaccination health checker” surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS) to characterize the initial safety of mRNA COVID-19 vaccines in pregnant people.

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length SARS-CoV-2 spike protein in a prefusion-stabilized conformation.

Individual registration for the EAN 2021 Congress is now back online, with a 10% discount available until May 10!